In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Yields on European government bonds remained elevated, with the German 10-year bund yield hitting its highest level in six ...

Deutsche Bank analyst Emmanuel Papadakis lowered the firm’s price target on Novo Nordisk (NVO) to DKK 900 from DKK 1,000 and keeps a Buy rating ...

Investing.com – Denmark stocks were higher after the close on Wednesday, as gains in the Personal & Household Goods, Industrials and Chemicals sectors led shares higher. At the... Investing.com ...

Hotter-than-expected jobs data and bond yields pressured stocks, resulting in weekly losses for all three indexes ...

U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The semiconductor maker has underperformed peers amid a contrast between the haves and the have-nots in the chip sector, the bank says.